...
首页> 外文期刊>Journal of Clinical Medicine Research >A Controllable Inflammatory Response and Temporary Abnormal Coagulation in Moderate Disease of COVID-19 in Wuhan, China
【24h】

A Controllable Inflammatory Response and Temporary Abnormal Coagulation in Moderate Disease of COVID-19 in Wuhan, China

机译:中国武汉武汉科研中等疾病可控炎症反应及临时凝血

获取原文
           

摘要

Background: The coronavirus disease 2019 (COVID-19) is now a worldwide challenge for public health. Among 7 million patients, about 80% present mild to moderate disease, but studies dedicate to these patients are actually scarce. The aim of our study is to clarify the characteristics of laboratory test index of COVID-19 patient with moderate symptoms during the first wave of the pandemic in Wuhan, China. Methods: In this retrospective cohort study, we included 107 adult inpatients with confirmed moderate disease of COVID-19 from the Affiliated Hospital of Jianghan University during February and early March 2020. All of these patients were recovered from COVID-19 and discharged from hospital. Demographic, clinical, and laboratory data of admission and discharge were extracted from electronic medical records and analyzed using SPSS, as well as among young, middle age and elderly people. Results: The median age of this cohort of patients was 56.0 years. And the median hospitalization time was 16 days. Common clinical manifestations included fever, cough, asthenia and shortness of breath. On admission, laboratory results showed normal or increased neutrophil ratio, low lymphocyte count, decreased hemoglobin level, and increased inflammatory indicators (erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)); and some patients were complicated with coagulation disorder and myocardial damage. Furthermore, patients older than 60 years had statistically higher CRP, ESR and fibrinogen level. As the health condition was improved at discharge, the median level of most laboratory results were in the normal range except hemoglobin and related blood cell count, as well as inflammatory indicator ESR. And patients older than 60 years showed slower recovery on coagulation parameters when compared to younger patients. Conclusions: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces a controllable inflammatory response in moderate disease of COVID-19 in Wuhan, China. Since patients older than 60 years had higher inflammatory state and more dysregulated coagulation condition, it might be essential to closely assess their illness.
机译:背景:2019年冠状病毒疾病(Covid-19)现在是公共卫生的全世界挑战。在700万患者中,大约80%的轻度至中度疾病,但研究这些患者的研究实际上是稀缺的。我们的研究目的是阐明Covid-19患者的实验室试验指数的特征,在武汉大流行中的中等症状中具有中度症状。方法:在这项回顾性队列研究中,我们在2月及2020年3月初将107名成人住院患者与江汉大学附属医院的Covid-19有确诊中度疾病。所有这些患者从Covid-19中恢复并从医院排放。从电子医疗记录中提取了人口,临床,临床和实验室数据,并用SPSS和年轻人,中年和老年人分析。结果:这种患者的中位年龄为56.0岁。和中位住院时间为16天。常见的临床表现包括发烧,咳嗽,哮喘和呼吸急促。在入院时,实验室结果显示中性粒细胞比率,低淋巴细胞计数,降低血红蛋白水平,以及增加的炎症指标(ERYTHROCYTE沉降率(ESR)和C反应蛋白(CRP));有些患者对凝血障碍和心肌损伤很复杂。此外,60岁的患者具有统计学上较高的CRP,ESR和纤维蛋白原水平。由于健康状况在出院时得到改善,大多数实验室结果的中值水平在血红蛋白和相关血细胞计数以及炎症指标ESR之外的正常范围内。与年轻患者相比,60岁以上的患者在凝血参数上表现出较慢的恢复。结论:严重的急性呼吸综合征冠状病毒2(SARS-COV-2)感染诱导武汉Covid-19中度疾病的可控炎症反应。由于60岁以上的患者具有较高的炎症状态和更令人遗憾的凝血状况,因此必须密切评估其疾病至关重要。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号